Advertisement

Osteoporosis International

, Volume 17, Issue 7, pp 986–995 | Cite as

Reductions in degree of mineralization and enzymatic collagen cross-links and increases in glycation-induced pentosidine in the femoral neck cortex in cases of femoral neck fracture

  • M. Saito
  • K. Fujii
  • S. Soshi
  • T. Tanaka
Original Article

Abstract

Introduction

Enzymatic and glycation-induced nonenzymatic cross-links play important roles in the expression of bone strength. The cross-link pattern is affected by tissue maturation and senescence. The aim of our study was to understand the distinctive posttranslational modifications of collagen in areas with different degrees of mineralization with and without hip fracture.

Methods

Sixteen female cases of intracapsular hip fracture (78±6 years) and 16 age- and gender-matched postmortem controls (76±6 years) were included in this study. A sample of each femoral neck cortex was fractionated into low (1.7 to 2.0 g/ml) and high (>2.0 g/ml) density portions. The contents of enzymatic cross-links (dihydroxylysinonorleucine, hydroxylysinonorleucine, lysinonorleucine, pyridinoline, and deoxypyridinoline) and nonenzymatic cross-links (pentosidine) and the extent of lysine (Lys) hydroxylation were determined in each fraction.

Results

In the controls, there was no significant difference in the contents of enzymatic cross-links between low- and high-mineralized bone fractions whereas pentosidine content was significantly higher in high-mineralized bone compared with low-mineralized bone (p=0.0014). When comparing enzymatic cross-link contents between controls and fracture cases, a trend toward lower (p=0.0961) cross-link content in low-mineralized bone and a significant reduction (p<0.0001) in high-mineralized bone were observed. Pentosidine content of low-mineralized bone was significantly higher in fracture cases than in controls (p<0.0001). The extent of Lys hydroxylation was significantly higher in fracture cases than in controls (p<0.001). The higher hydroxylation of Lys in collagen from fracture cases relative to controls was associated with significantly higher values of hydroxylysine-derived cross-link such that the enzymatic cross-link patterns correlated with the extent of Lys hydroxylation in the collagen molecules.

Conclusions

These results suggest that reductions in the degree of mineralization and enzymatic cross-links and excessive formation of pentosidine may play an important role in explaining poor bone quality in osteoporosis.

Keywords

Bone quality Cortical bone Cross-links Degree of mineralization Osteoporosis Pentosidine 

Notes

Acknowledgements

The authors are grateful to Dr. Noriaki Ishioka (Japan Aerospace Exploration Agency, JAXA, Japan) for experimental discussions and technical support. We also appreciate Miss Kazumi Hirakawa and Akiko Kuhara (Jikei University School of medicine) for technical support.

References

  1. 1.
    Burr DB (2002) Bone material properties and mineral matrix contributions to fracture risk or age in women and men. J Musculoskelet Neuronal Interact 2:201–204PubMedGoogle Scholar
  2. 2.
    Paschalis EP, Shne E, Lyritis D, Skaeantavos G, Mandelsohn R, Boskey AL (2004) Bone fragility and collagen cross-links. J Bone Miner Res 19:2000–2004PubMedCrossRefGoogle Scholar
  3. 3.
    Gearnero P, Delmas PD (2004) Contribution of bone mineral density and bone turnover markers to the estimation of risk of Osteoporotic fracture in postmenopausal women. J Musculoskelet Neuronal Interact 4:50–63Google Scholar
  4. 4.
    Turner CH (2002) Biomechanics of bone: determinants of skeletal fragility and bone quality. Osteopor Int 13:97–104CrossRefGoogle Scholar
  5. 5.
    Mori S, Harruff R, Ammrosius W, Burr DB (1997) Trabecular bone volume and microdamage accumulation on the femoral heads of women with and without femoral neck fractures. Bone 21:521–526PubMedCrossRefGoogle Scholar
  6. 6.
    Wang X, Shen X, Li X, Agrawal CM (2002) Age-related changes in the collagen network and toughness of bone. Bone 31:1–7PubMedCrossRefGoogle Scholar
  7. 7.
    Mashiba T, Mori S, Burr DB, Komatsubara S, Cao Y, Manabe T, Norimatsu H (2005) The effects of suppressed bone remodeling by bisphosphonates on microdamage accumulation and degree of mineralization in the cortical bone of dog rib. J Bone Miner Metab 23(Suppl):36–42PubMedCrossRefGoogle Scholar
  8. 8.
    Jowsey J (1964) Variation in bone mineralization with age and disease. In: Bone Biodynamics, Little Brown, Boston, p 461–479Google Scholar
  9. 9.
    Boivin GY, Chavassieuv, Santora AC, Yates J, Meunier PJ (2000) Alendronate increasing the mean degree of mineralization of bone tissue in osteoporotic women. Bone 27:687–694PubMedCrossRefGoogle Scholar
  10. 10.
    Grynpas MD, Hunter GK (1988) Bone mineral and glycosaminoglycans in newborn and mature rabbits. J Bone Miner Res 3:159–164PubMedGoogle Scholar
  11. 11.
    Russell JE, Avioli LA (1972) Effect of experimental chronic renal insufficiency on bone mineral and collagen maturation. J Clin Invest 51:3072–3079PubMedGoogle Scholar
  12. 12.
    Caballero-Alias AM, Loveridge N, Pitsillides A, Parker M, Kaptoge S, Lyon A, Reeve J (2005) Osteocytic expression of constitutive NO synthase isoforms in the femora neck cortex: a case-control study of intracapsular hip fracture. J Bone Miner Res 20:268–273PubMedCrossRefGoogle Scholar
  13. 13.
    Muthusami S, Ramachandran I, Muthusamy B, Vasudevan G, Prabhu V, Subramaniam V, Jagadeesan A, Narasimhan S (2005) Ovariectomy induces oxidative stress and impairs bone antioxidant system in adult rats. Clin Chim Acta 360:81–86PubMedCrossRefGoogle Scholar
  14. 14.
    Oxlund H, Mosekilde L, Ortoft G (1996) Reduced concentration of collagen reducible crosslinks in human trabecular bone with respect to age and osteoporosis. Bone 19:479–484PubMedCrossRefGoogle Scholar
  15. 15.
    Oxlund H, Barckman M, Ortoft G, Andreassen TT (1995) Reduced concentrations of collagen cross-links are associated with reduced strength of bone. Bone 17:365S–371SPubMedGoogle Scholar
  16. 16.
    Zioupos P, Currey JD, Hamer AJ (1999) The role of collagen in the declining mechanical properties of aging human cortical bone. J Biomed Mater Res 45:108–116PubMedCrossRefGoogle Scholar
  17. 17.
    Vashishth D, Gibson GJ, Khoury JI, Schaffler MB, Kimura J, Fyhrie DP (2001) Influence of nonenzymatic glycation on biomechanical properties of cortical bone. Bone 28:195–201PubMedCrossRefGoogle Scholar
  18. 18.
    Kuboki Y, Kudo A, Mizuno M, Kawamura M (1992) Time-dependent changes of collagen cross-links and their precursors in the culture of osteogenic cells. Calcif Tissue Int 50:473–480PubMedCrossRefGoogle Scholar
  19. 19.
    Uzawa K, Grzesik WJ, Nishiura T, Kuznetsov SA, Robey PG, Brenner DA, Yamauchi M (1999) Differential expression of human lysyl hydroxylase genes, lysyl hydroxylation, and cross-linking of type I collagen during osteoblastic differentiation in vitro. J Bone Miner Res 14:1272–1280PubMedCrossRefGoogle Scholar
  20. 20.
    Yamauchi M, Katz EP (1993) The post-translational chemistry and molecular packing of mineralizing tendon collagens. Connect Tissue Res 29:81–98PubMedGoogle Scholar
  21. 21.
    Saito M, Soshi S, Fujii K (2003) Effect of hyper- and microgravity on collagen post-translational controls of MC3T3-E1 osteoblasts. J Bone Miner Res 18:1695–1705PubMedCrossRefGoogle Scholar
  22. 22.
    Saito M, Sohsi S, Tanaka T, Fujii K (2004) Intensity-related differences in collagen post-traslational modification in MC3T3-E1 osteoblasts after exposure to low and high intensity pulsed ultrasound. Bone 35:644–655PubMedCrossRefGoogle Scholar
  23. 23.
    Saito M, Fujii K, Tanaka T, Soshi S (2004) Effect of low- and high-intensity pulsed ultrasound on collagen post-translational modifications in MC3T3-E1 osteoblasts. Calcif Tissue Int 75:384–385PubMedCrossRefGoogle Scholar
  24. 24.
    Eyre DR, Dickson IR, Van Ness K (1988) Collagen cross-linking in human bone and articular cartilage. Age-related changes in the content of mature hydroxypyridinium residues. Biochem J 252:495–500PubMedGoogle Scholar
  25. 25.
    Saito M, Marumo K, Fujii K, Ishioka N (1997) Single column high - performance liquid chromatographic - fluorescence detection of immature, mature and senescent cross-links of collagen. Anal Biochem 253:26–32PubMedCrossRefGoogle Scholar
  26. 26.
    Marumo K, Saito M, Yamagishi T, Fujii K (2005) The “ligamentization” process in human anterior cruciate ligament reconstruction with autogenous patellar and hamstring tendons. Am J Sports Med 33:1166–1173PubMedCrossRefGoogle Scholar
  27. 27.
    Bank RA, Robins SP, Wijmenga C, Breslau-Siderius LJ, Bardoel AF, van der Sluijs HA, Pruijs HE, TeKoppele JM (1999) Defective collagen crosslinking in bone, but not in ligament or cartilage, in Bruck syndrome: indications for a bone-specific telopeptide lysyl hydroxylase on chromosome 17. Proc Natl Acad Sci USA 96:1054–1058PubMedCrossRefGoogle Scholar
  28. 28.
    Bailey AJ, Knott L (1999) Molecular changes in bone collagen in osteoporosis and osteoarthritis in the elderly. Exp Gerontol 34:337–351PubMedCrossRefGoogle Scholar
  29. 29.
    Pornprasertsuk S, Duarte WR, Mochida Y, Yamauchi M (2005) Overexpression of lysyl hydroxylase-2b leads to defective collagen fibrillogenesis and matrix mineralization. J Bone Miner Res 20:81–87PubMedGoogle Scholar
  30. 30.
    Paul RG, Bailey AJ (1996) Glycation of collagen: the basis of its central role in the late complications of ageing and diabetes. Int J Biochem Cell Biol 28:1297–1310PubMedCrossRefGoogle Scholar
  31. 31.
    Sell DR, Monnier VM (1989) Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process. J Biol Chem 264:21597–21602PubMedGoogle Scholar
  32. 32.
    Katayama Y, Akatsu T, Yamamoto M, Kugai N, Nagata N (1996) Role of nonenzymatic glycosylation of type I collagen in diabetic osteopenia. J Bone Miner Res 11:931–937PubMedCrossRefGoogle Scholar
  33. 33.
    Saito M (1999) Age-related changes in biochemical characteristics of collagen from human weight-bearing and non-weight-bearing bone. Tokyo Jikeikai Medical Journal 114:327–337 (in Japanese)Google Scholar
  34. 34.
    Termine JD, Eanes ED, Greenfield DJ, Nylen MU (1973) Hydrazine deproteinated bone mineral. Calcif Tissue Res 12:73–90PubMedCrossRefGoogle Scholar
  35. 35.
    Sodek KL, Tupy JH, Sodek J, Grynpas MD (2000) Relationships between bone protein and mineral in developing porcine bone and calvaria. Bone 26:189–198PubMedCrossRefGoogle Scholar
  36. 36.
    Grynpas M, Marie PJ (1990) Effects of low doses of strontium on bone quality and quantity in rats. Bone 11:313–319PubMedCrossRefGoogle Scholar
  37. 37.
    Vukicevic S, Stavljenic A, Boll T, Vujicic G, Degenhardt C, Cervar M, Krempien B (1989) Effects of parathyroidectomy on tissue calcium, phosphorus, magnesium, and copper concentrations in aluminum-loaded uremic rats. Biol Trace Elem Res 22:45–53PubMedCrossRefGoogle Scholar
  38. 38.
    Eyre DR, Koob TJ, Van Ness KP (1984) Quantification of hydroxypyridinium crosslinks in collagen by High-Performance Liquid Chromatography. Anal Biochem 137:380–388PubMedCrossRefGoogle Scholar
  39. 39.
    Paschalis EP, Verdelis K, Doty SB, Boskey AL, Mendelsohn R, Yamauchi M (2001) Spectroscopic characterization of collagen cross-links in bone. J Bone Miner Res 16:1821–1828PubMedCrossRefGoogle Scholar
  40. 40.
    Blank RD, Baldini TH, Kaufman M, Bailey S, Gupta R, Yershov Y, Boskey AL, Coppersmith SN, Demant P, Paschalis EP (2003) Spectroscopically determined collagen Pyr/deH-DHLNL cross-link ratio and crystallinity indices differ markedly in recombinate congenic mice with divergent calculated bone tissue strength. Connect Tissue Res 44:134–142PubMedCrossRefGoogle Scholar
  41. 41.
    Bonar LC, Roufosse AH, Sabine WK, Grynpas MD, Glimcher MJ (1983) X-ray diffraction studies of the crystallinity of bone mineral in newly-synthesized and density fractionated bone. Calcif Tissue Int 35:202–209PubMedCrossRefGoogle Scholar
  42. 42.
    Akkus O, Polyakoya-Akkus A, Adar F, Schaffler MB (2003) Aging of microstructural components in human compact bone. J Bone Miner Res 18:1012–1019PubMedCrossRefGoogle Scholar
  43. 43.
    Atsawasuwan P, Mochida Y, Parisuthiman D, Yamauchi M (2005) Expression of lysyl oxidase isoforms in MC3T3-E1 osteoblastic cells. Biochem Biophys Res Commun 327:1042–1046PubMedCrossRefGoogle Scholar
  44. 44.
    Knott L, Tarlton JF, Bailey AJ (1997) Chemistry of collagen cross-linking: biochemical changes in collagen during the partial mineralization of turkey leg tendon. Biochem J 322:535–542PubMedGoogle Scholar
  45. 45.
    Fujii K, Kuboki Y, Sasaki S (1976) Aging of human bone and articular cartilage collagen: changes in the reducible cross-links and their precursors. Gerontology 22:363–370PubMedCrossRefGoogle Scholar
  46. 46.
    Bailey AJ, Wotton SF, Simes TJ, Thompson PW (1992) Post-translational modification in the collagen human osteoporotic femoral head. Biochem Biophys Res Commun 185:801–805PubMedCrossRefGoogle Scholar
  47. 47.
    Robins SP (1982) Analysis of the crosslinking components in the collagen and elastin. Methods Biochem Anal 28:329–379PubMedCrossRefGoogle Scholar
  48. 48.
    Reynolds TM, Marshall PD, Brain AM (1992) Hip fracture patients may be vitamin B6 deficient. Controlled study of serum pyridoxal 5 phosphate. Acta Orthop Scand 63:635–638PubMedGoogle Scholar
  49. 49.
    Bird TA, Levene CI (1982) Lysyl oxidase: evidence that pyridoxal phosphate is a co-factor. Biochem Biophys Res Commun 108:1172–1180PubMedCrossRefGoogle Scholar
  50. 50.
    Fujii K, Kajiwara T, Kurosu H (1979) Effect of vitamin B6 deficiency on the crosslink formation of collagen. FEBS Lett 97:193–195PubMedCrossRefGoogle Scholar
  51. 51.
    Masse PG, Rimnac CM, Yamauchi M, Coburn SP, Rucker RB, Howell DS, Boskey AL (1996) Pyridoxine deficiency affects biomechanical properties of chick tibial bone. Bone 18:567–574PubMedCrossRefGoogle Scholar
  52. 52.
    McLean RR, Jacques PF, Selhub J, Tucker KL, Samelson EJ, Broe KE, Hannan MT, Cupples LA, Kiel DP (2004) Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 350:2042–2049PubMedCrossRefGoogle Scholar
  53. 53.
    van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, van der Klift M, de Jonge R, Lindemans J, de Groot LC, Hofman A, Witteman JC, van Leeuwen JP, Breteler MM, Lips P, Pols HA, Uitterlinden AG (2004) Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 350:2033–2041PubMedCrossRefGoogle Scholar
  54. 54.
    Khan M, Yamauchi M, Srisawasdi S, Stiner D, Doty S, Paschalis EP, Boskey AL (2001) Homocysteine decrease chondrocyte-mediated matrix mineralization in differentiating limb-bud mesenchymal cell micro-mass cultures. Bone 28:387–398PubMedCrossRefGoogle Scholar
  55. 55.
    Raposo B, Rodriguez C, Martinez-Gonzalez J, Badimon L (2004) High level of homocysteine inhibit lysyl oxidase (LOX) and downregulate LOX expression in vascular endothelial cells. Atherosclerosis 177:1–8PubMedCrossRefGoogle Scholar
  56. 56.
    Lubec B, Fang-Kircher S, Lubec T, Blom HJ, Boers GHJ (1996) Evidence for McKusick’s hypothesis of deficient collagen cross-linking in patients with homocystinuria. Biochim Biophys Acta 1315:159–162PubMedGoogle Scholar
  57. 57.
    Reiser KM (1991) Nonenzymatic glycation of collagen in aging and diabetes. Proc Soc Exp Biol Med 196:17–29PubMedGoogle Scholar
  58. 58.
    Garnero P, Borel O, Gineyts E, Duboeuf F, Solberg H, Bouxsein ML, Christiansen C, Delmas PD (2005) Extracellular post-translational modifications of collagen are major determinants of biomechanical properties of fetal bovine cortical bone. Bone Nov 2;[Epub ahead of print]Google Scholar
  59. 59.
    Baynes JW (1991) Role of oxidative stress in development of complications in diabetes. Diabetes 40:405–412PubMedCrossRefGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2006

Authors and Affiliations

  1. 1.Department of Orthopaedic SurgeryJikei University School of MedicineTokyo,Japan

Personalised recommendations